REFRACTORY THYROID GLAND CARCINOMA
Clinical trials for REFRACTORY THYROID GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY THYROID GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for REFRACTORY THYROID GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: trial targets a key genetic driver
Disease control OngoingThis study is testing a drug called tipifarnib in children and young adults whose advanced cancers have a specific genetic change in a gene called HRAS. The goal is to see if the drug can shrink tumors and control the disease. Participants take the drug as a pill or through a fee…
Matched conditions: REFRACTORY THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo trial offers hope for Tough-to-Treat thyroid cancer
Disease control OngoingThis study is testing whether two targeted cancer drugs (encorafenib and binimetinib), given with or without an immunotherapy drug (nivolumab), can help control advanced thyroid cancer that has a specific genetic change (BRAF V600 mutation) and has stopped responding to standard …
Matched conditions: REFRACTORY THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo aims to Re-Sensitize tough thyroid cancers to standard treatment
Disease control OngoingThis study is testing if adding an oral drug called trametinib can make radioactive iodine treatment work again for people with advanced thyroid cancer that has spread or come back and no longer responds to iodine. The goal is to see if trametinib helps the cancer absorb more iod…
Matched conditions: REFRACTORY THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug combo aims to tame tough thyroid cancers
Disease control OngoingThis study is testing whether a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—can help control advanced thyroid cancer that has stopped responding to radioactive iodine and has worsened after one prior targeted therapy. The goal is to see if this three-drug a…
Matched conditions: REFRACTORY THYROID GLAND CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC